Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review.

Booth RA, Hill SA, Don-Wauchope A, Santaguida PL, Oremus M, McKelvie R, Balion C, Brown JA, Ali U, Bustamam A, Sohel N, Raina P.

Heart Fail Rev. 2014 Aug;19(4):439-51. doi: 10.1007/s10741-014-9445-8. Erratum in: Heart Fail Rev. 2014 Aug;19(4):565.

PMID:
24969534
2.

Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence.

Hill SA, Booth RA, Santaguida PL, Don-Wauchope A, Brown JA, Oremus M, Ali U, Bustamam A, Sohel N, McKelvie R, Balion C, Raina P.

Heart Fail Rev. 2014 Aug;19(4):421-38. doi: 10.1007/s10741-014-9447-6. Review. Erratum in: Heart Fail Rev. 2014 Aug;19(4):565.

PMID:
24957908
3.

Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.

Balion C, Santaguida PL, Hill S, Worster A, McQueen M, Oremus M, McKelvie R, Booker L, Fagbemi J, Reichert S, Raina P.

Evid Rep Technol Assess (Full Rep). 2006 Sep;(142):1-147. Review.

4.

Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.

Han ZJ, Wu XD, Cheng JJ, Zhao SD, Gao MZ, Huang HY, Gu B, Ma P, Chen Y, Wang JH, Yang CJ, Yan ZH.

PLoS One. 2015 Aug 5;10(8):e0134376. doi: 10.1371/journal.pone.0134376. eCollection 2015. Review.

5.

Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.

Christenson RH, Azzazy HM, Duh SH, Maynard S, Seliger SL, Defilippi CR.

Clin Chem. 2010 Apr;56(4):633-41. doi: 10.1373/clinchem.2009.129742. Epub 2010 Feb 18.

6.

A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods.

Oremus M, McKelvie R, Don-Wauchope A, Santaguida PL, Ali U, Balion C, Hill S, Booth R, Brown JA, Bustamam A, Sohel N, Raina P.

Heart Fail Rev. 2014 Aug;19(4):413-9. doi: 10.1007/s10741-014-9440-0. Review. Erratum in: Heart Fail Rev. 2014 Aug;19(4):565.

PMID:
24953975
8.

Comparative value of BNP and NT-proBNP in diagnosis of heart failure.

Fonseca C, Sarmento PM, Minez A, Gonçalves E, Covas R, Dias AR, Pina MJ, Ceia F.

Rev Port Cardiol. 2004 Jul-Aug;23(7-8):979-91. English, Portuguese.

9.

Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.

Januzzi JL Jr, Chen-Tournoux AA, Moe G.

Am J Cardiol. 2008 Feb 4;101(3A):29-38. doi: 10.1016/j.amjcard.2007.11.017. Review.

PMID:
18243855
10.
11.

[Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].

El Mahmoud R, Alibay Y, Brun-Ney D, Boulard JC, Dubourg O, Puy H, Jondeau G.

Arch Mal Coeur Vaiss. 2006 Mar;99(3):201-7. French.

PMID:
16618022
12.

B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.

Jafri L, Kashif W, Tai J, Siddiqui I, Azam I, Shahzad H, Ghani F.

BMC Nephrol. 2013 May 31;14:117. doi: 10.1186/1471-2369-14-117.

13.

BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review.

Santaguida PL, Don-Wauchope AC, Oremus M, McKelvie R, Ali U, Hill SA, Balion C, Booth RA, Brown JA, Bustamam A, Sohel N, Raina P.

Heart Fail Rev. 2014 Aug;19(4):453-70. doi: 10.1007/s10741-014-9442-y. Review.

PMID:
25062653
14.

Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review.

Worster A, Balion CM, Hill SA, Santaguida P, Ismaila A, McKelvie R, Reichert SM, McQueen MJ, Booker L, Raina PS.

Clin Biochem. 2008 Mar;41(4-5):250-9. Epub 2007 Aug 24. Review.

PMID:
17915204
15.

BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure.

Oremus M, Don-Wauchope A, McKelvie R, Santaguida PL, Hill S, Balion C, Booth R, Brown JA, Ali U, Bustamam A, Sohel N, Raina P.

Heart Fail Rev. 2014 Aug;19(4):471-505. doi: 10.1007/s10741-014-9439-6. Review. Erratum in: Heart Fail Rev. 2014 Aug;19(4):565.

PMID:
24986335
16.

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN; Val-HeFT Investigators.

Clin Chem. 2006 Aug;52(8):1528-38. Epub 2006 Jun 15.

17.

[Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure].

Rutten JH, Boomsma F, Van den Meiracker AH.

Ned Tijdschr Geneeskd. 2007 Nov 17;151(46):2553-7. Review. Dutch.

PMID:
18074722
18.

Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.

deFilippi CR, Seliger SL, Maynard S, Christenson RH.

Clin Chem. 2007 Aug;53(8):1511-9. Epub 2007 Jun 22.

19.

[Amino-terminal pro-brain natriuretic peptide and brain natriuretic peptide measurements under various detection conditions in patients with chronic heart failure].

Wang WJ, Zhang XM, Wang Q, Wen DM, Ouyang NL, Cui YL, Li F.

Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Aug;39(8):695-9. Chinese.

PMID:
22169413
20.

Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.

Omland T.

Crit Care Med. 2008 Jan;36(1 Suppl):S17-27. doi: 10.1097/01.CCM.0000296266.74913.85. Review.

PMID:
18158473

Supplemental Content

Support Center